Richard P. Junghans

Richard P. Junghans PhD MD is Associate Professor in the Hematology-Oncology Division, Department of Medicine, Boston University School of Medicine and President of IT Bio, LLC. Richard has a long term interest in innovative immunotherapies and specifically cell therapies. He secured FDA Investigational New Drug status for 7 distinct antibody and gene therapy agents and established two on-campus cGMP facilities for gene therapy applications. He has participated as an expert in FDA and NIH colloquia on gene therapy, and has been a member of the Scientific Advisory Board of the National Gene Vector Lab (NGVL). He has served on the Cancer Immunology & Immunotherapy (CII) and Clinical Oncology (CONC) study sections of the NIH. He was recipient of the ASCO Career Development Award, the AACR Young Investigator Award, and the NCI Research Career Development Award and was designated as an American Cancer Society Research Scholar. His research has been supported by more than $26 million in research funding and he has published more than 100 scientific articles.